# Effect of Vivomixx® on Neuroinflammation in Patients Withs Cirrhosis

> **NCT03236090** · NA · WITHDRAWN · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau**

## Conditions studied

- Cirrhosis, Liver

## Interventions

- **DIETARY_SUPPLEMENT:** Vivomixx

## Key facts

- **NCT ID:** NCT03236090
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-07-15
- **Primary completion:** 2018-03-09
- **Final completion:** 2018-03-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Problems to recruit patients due to exclusion criteria
- **Last updated:** 2018-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03236090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03236090, "Effect of Vivomixx® on Neuroinflammation in Patients Withs Cirrhosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03236090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*